
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief

Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870

World Leaders to Descend on Singapore for the 10th Milken Institute Asia Summit, Celebrating a Decade of Progress, Action, and Impact
